← Eichor
Study identifier: NCT04073706 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Sentinel Node Biopsy in Endometrial Cancer

Condition: Endometrial Cancer Stage I · Sentinel Lymph Node · Surgery  ·  Sponsor: Queensland Centre for Gynaecological Cancer

PhasePhase 3
Planned participants760
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Endometrial cancer (EC) is the most common gynaecological cancer. Current treatment of EC typically includes removal of the uterus and to determine the extent of the disease (removal of fallopian tubes, ovaries \& if required a lymph node dissection (surgical staging)). While lymph node dissection may be valuable to guide the need for adjuvant treatment (chemo or radiotherapy) after surgery, it has been a topic of controversy for the last 30 years. In some patients it causes morbidity, specifically lymphoedema. This recently has been replaced with sentinel node biopsy (SNB). It requires an injection of a dye into the cervix with specific equipment \& surgical dissection of the lymph node in which the dye first becomes visible. Despite this promising proposition \& similar to a lymph node dissection, the value to patients, cost effectiveness \& potential harms (e.g. lymphedema) of SNB compared to no-node dissection in EC has never been established. Aim: determine the value of SNB for patients, the healthcare system and exclude detriment to patients using a randomised approach 1:1. Stage 1 - 444 patients. Stage 2 additional 316 patients. Primary Outcome Stage 1: Proportion of participants returning to usual daily activities at 12 months from surgery using the EQ-5D which will determine when women in both groups can return to their usual activities. Primary Outcome Stage 2: Treatment non-inferiority as evaluated by disease-free survival status at 4.5 years post-surgery, as m…

This description comes directly from the study's public registry record.

Talk to the study team

Grace Ngiam  ·  +61 7 3346 5590  ·  endo3trial@uq.edu.au

Sara Baniahmadi  ·  +61733465073  ·  sara.baniahmadi@health.qld.gov.au

Always discuss trial participation with your own doctor first.

Locations (19)

Houston Methodist HospitalHouston, Texas, United StatesRecruiting
Hospital BritanicoBuenos Aires, Ciudad Autónoma de Buenos Aires (caba), ArgentinaNot Yet Recruiting
Chris O'Brien LifehouseCamperdown, New South Wales, AustraliaRecruiting
Liverpool HospitalLiverpool, New South Wales, AustraliaRecruiting
The Wesley HospitalAuchenflower, Queensland, AustraliaRecruiting
Buderim Private HospitalBuderim, Queensland, AustraliaRecruiting
North West Private HospitalEverton Park, Queensland, AustraliaRecruiting
Royal Brisbane and Women's HospitalHerston, Queensland, AustraliaRecruiting
Mater HospitalSouth Brisbane, Queensland, AustraliaRecruiting
Gold Coast University HospitalSouthport, Queensland, AustraliaNot Yet Recruiting
St Andrews War Memorial HospitalSpring Hill, Queensland, AustraliaRecruiting
Mercy Hospital for WomenHeidelberg, Victoria, AustraliaRecruiting

+ 7 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04073706